Accessibility Menu

Hims & Hers (HIMS 1.62%) may not be a name you think of in artificial intelligence, but it should be. The company is building AI tools to help people be healthier, and there's a lot of optionality for the use cases long-term. Management recently outlined some of their vision and investors should expect some launches later this year. If done right, AI is the kind of disruption in healthcare that could make Hims & Hers one of the biggest winners in the market long-term.

*Stock prices used were end-of-day prices of April 3, 2026. The video was published on April 10, 2026.

Read Next

About the Author

Travis Hoium
Travis Hoium is a contributing Motley Fool stock market analyst covering solar energy, technology, and growth stocks. Before The Motley Fool, Travis was a mechanical engineer at 3M and founded a virtual reality company. He holds a bachelor’s degree in mechanical engineering and a master’s degree in business administration from the University of Minnesota.
TMFFlushDraw
X@travishoium

Travis Hoium has positions in Hims & Hers Health. The Motley Fool has positions in and recommends Hims & Hers Health. The Motley Fool has a disclosure policy. Travis Hoium is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool.

Stocks Mentioned

Hims & Hers Health Stock Quote
Hims & Hers Health
NYSE: HIMS
$33.39
(-1.62%)-$0.55
Stock Advisor

Motley Fool Stock Advisor’s Latest Pick

Get Access
---% Avg Return

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services